Award

Senolytic and Senostatic Drugs for the Treatment of Angiotensin Ii-induced Reactive Cardiac Fibrosis

Amount: CLP 222,100
Funding type: research
Funder scheme: FONDECYT - REGULAR
Start date: 2021-01-01
End date: 2025-12-31
Investigator: GUILLERMO DIAZ ARAYA
Institution: UNIVERSIDAD DE CHILE
Funded outputs count: 51
Funder award ID: 1210627
OpenAlex ID: G8892784977
2026 · Claudio Espinoza-Perez, José Miguel Osorio, et al. · Frontiers in Pharmacology
2023 · Renatto Anfossi, Raúl Vivar, et al. · Frontiers in Cell and Developmental Biology · 9
2022 · Jenaro A. Espitia-Corredor, Licia Shamoon, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 37
2022 · Águeda González Rodríguez, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain, et al. · IBJ Plus
2022 · Centro de Biología Molecular Severo Ochoa-CSIC, UAM, Madrid, Madrid, Spain, G Cerro-Tello, et al. · IBJ Plus
2022 · Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernandez Almagro 3, Madrid, Spain., Valentín Fuster, et al. · IBJ Plus
2022 · Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Program of Tissue and Organ Homeostasis, Madrid, Spain., Rafael Casado-Navarro, et al. · IBJ Plus
2022 · AF Caballero-Bermejo, A Sancho-López, et al. · IBJ Plus
2022 · Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), C/Nicolas Cabrera 1, Universidad Autónoma de Madrid, Madrid 28049, Spain, Lara Ordóñez-Gutiérrez, et al. · IBJ Plus
2022 · Céline Decouty Pérez, Instituto Teófilo Hernando de I+D del Medicamento, Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, España., et al. · IBJ Plus
2022 · Lorena García-García, Keren Pastora, et al. · IBJ Plus
Background: Nonalcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease worldwide, being nonalcoholic steatohepatitis (NASH) its most clinically relevant form. Given the risks associated with taking a liver biopsy, the design of accurate non-invasive methods to identify NASH patients is of upmost importance. BMP2 plays a key role in metabolic homeostasis; however, little is known about its involvement in NAFLD onset and progression. This study aimed to elucidate the impact of BMP2 in NAFLD pathophysiology. Methods: Hepatic and circulating levels of BMP2 were quantified in serum and liver specimens from 115 biopsyproven NAFLD patients and 75 subjects with histologically normal liver (NL). In addition, BMP2 content and release was determined in cultured human hepatocytes upon palmitic acid (PA) overload. Results: We found that BMP2 expression was abnormally increased in livers from NAFLD patients than in subjects with NL and this was reflected in higher serum BMP2 levels. Notably, we observed that PA upregulated BMP2 expression and secretion by human hepatocytes. An algorithm based on serum BMP2 levels and clinically relevant variables to NAFLD showed an AUROC of 0.886 (95%CI, 0.83–0.94) to discriminate NASH. We used this algorithm to develop SAN (Screening Algorithm for NASH): a SAN < 0.2 implied a low risk and a SAN ≥ 0.6 indicated high risk of NASH diagnosis. Conclusion: This proof-of-concept study shows BMP2 as a new molecular target linked to NAFLD and introduces SAN as a simple and efficient algorithm to screen individuals at risk for NASH.
2022 · Instituto Cajal, Avenida Doctor Arce 37, Madrid, Spain., Cristina Martín-Monteagudo, et al. · IBJ Plus
2022 · Andrea Sánchez-Ruiz, Candela González-Arias1, et al. · IBJ Plus
2022 · Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas ", Manuel Gámez-Chiachio, et al. · IBJ Plus
2022 · Brenda Martínez-González, María Eugenia Soria, et al. · IBJ Plus
2022 · Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Andrés Vicente-Acosta, et al. · IBJ Plus
2022 · Licia Shamoon, Instituto de Investigaciones Sanitarias (IdiPAZ), Madrid, Spain., et al. · IBJ Plus
2022 · Experimental Pathology of Atherosclerosis Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Rocío Muñiz-Anquela, et al. · IBJ Plus
2022 · Departamento de Biologia Molecular. Universidad Autónoma de Madrid (UAM), Madrid, Spain., Eduardo Herrada, et al. · IBJ Plus
Year
Topic